Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that two abstracts representing additional data from several clinical trials of the investigational ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE